Did the government overpay for hundreds of drugs? It’s complicated

(By Ike Swetlitz for STAT)

WASHINGTON — It looked like the watchdog had found something big — in December 2017, a government report proclaimed that drug companies might have stiffed Medicaid over a billion dollars by pricing some brand-name drugs like generics. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.